FdaApplication
ANDA 210726
Identifiers
- fda_app_no: ANDA210726
Properties
| Property | Value |
|---|---|
| applicant_name | TEVA PHARMACEUTICALS USA INC |
| application_type | ANDA |
| approval_date | 2023-01-26 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ABIRATERONE ACETATE | ABIRATERONE ACETATE | 500MG | TABLET;ORAL |
1 product